These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2559892)
21. Changes in dengue and Japanese encephalitis (JE) antibody after JE vaccination. Quina MA; Thein S; Auvanich W; Okuno Y; Igarashi A; Fukai K Biken J; 1978 Dec; 21(4):149-59. PubMed ID: 754688 [TBL] [Abstract][Full Text] [Related]
22. Persistence of the immune response after vaccination with the Japanese encephalitis vaccine, IXIARO® in healthy adults: A five year follow-up study. Taucher C; Kollaritsch H; Dubischar KL Vaccine; 2019 May; 37(19):2529-2531. PubMed ID: 30962094 [TBL] [Abstract][Full Text] [Related]
23. Immune response in mice infected with the attenuated Japanese encephalitis vaccine strain SA14-14-2. Lee T; Komiya T; Watanabe K; Aizawa C; Hashimoto H Acta Virol; 1995 Jun; 39(3):161-4. PubMed ID: 8578998 [TBL] [Abstract][Full Text] [Related]
24. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine. Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388 [TBL] [Abstract][Full Text] [Related]
25. Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children. Ku CC; King CC; Lin CY; Hsu HC; Chen LY; Yueh YY; Chang GJ J Med Virol; 1994 Oct; 44(2):122-31. PubMed ID: 7852952 [TBL] [Abstract][Full Text] [Related]
26. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Beasley DW; Li L; Suderman MT; Guirakhoo F; Trent DW; Monath TP; Shope RE; Barrett AD Vaccine; 2004 Sep; 22(27-28):3722-6. PubMed ID: 15315852 [TBL] [Abstract][Full Text] [Related]
27. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies. Ferguson M; Johnes S; Li L; Heath A; Barrett A Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945 [TBL] [Abstract][Full Text] [Related]
28. Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships. Tseng HF; Tan HF; Chang CK; Huang WL; Ho WC Am J Infect Control; 2003 Nov; 31(7):435-40. PubMed ID: 14639442 [TBL] [Abstract][Full Text] [Related]
29. Safety & efficacy of Japanese encephalitis vaccine produced in India. Rao Bhau LN; Singh G; Gowal D; Saxena SN; Kobayashi M; Oya A; Yoshioka I Indian J Med Res; 1988 Oct; 88():301-7. PubMed ID: 2852169 [No Abstract] [Full Text] [Related]
30. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice. Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206 [TBL] [Abstract][Full Text] [Related]
31. Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51. Dubischar-Kastner K; Eder S; Buerger V; Gartner-Woelfl G; Kaltenboeck A; Schuller E; Tauber E; Klade C Vaccine; 2010 Jul; 28(32):5197-202. PubMed ID: 20541581 [TBL] [Abstract][Full Text] [Related]
32. Immunologic analysis induced by DNA vaccine encoding E protein of Beijing-1 strain derived from Japanese encephalitis virus. Feng GH; Liu N; Zhou Y; Zhai YZ; Li XM; Dou XG Intervirology; 2007; 50(2):93-8. PubMed ID: 17139185 [TBL] [Abstract][Full Text] [Related]
33. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study. Luo D; Yin H; Xili L; Song J; Wang Z Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706 [TBL] [Abstract][Full Text] [Related]
34. A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine. Puthanakit T; Aurpibul L; Yoksan S; Sirisanthana T; Sirisanthana V Vaccine; 2010 Aug; 28(36):5900-2. PubMed ID: 20600498 [TBL] [Abstract][Full Text] [Related]
35. A field trial of Japanese encephalitis vaccine produced in Thailand. Rojanasuphot S; Charoensuk O; Kitprayura D; Likityingvara C; Limpisthien S; Boonyindee S; Jivariyavej V; Ugchusak K Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):653-4. PubMed ID: 2561722 [No Abstract] [Full Text] [Related]
36. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632 [TBL] [Abstract][Full Text] [Related]
37. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice. Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134 [TBL] [Abstract][Full Text] [Related]
38. [Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines]. Guo W; Li L; Wu Z Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):97-9. PubMed ID: 10322719 [TBL] [Abstract][Full Text] [Related]
40. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine. Woolpert T; Staples JE; Faix DJ; Nett RJ; Kosoy OI; Biggerstaff BJ; Johnson BW; Sracic M; Fischer M Vaccine; 2012 Apr; 30(20):3090-6. PubMed ID: 22406277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]